Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Faster diagnosis and accurate prognosis for rheumatoid arthritis

Reference number
Coordinator Vacara AB
Funding from Vinnova SEK 3 000 000
Project duration May 2023 - April 2025
Status Ongoing
Venture Swelife and Medtech4Health - Collaborative Projects for Improved Health
Call Swelife and Medtech4Health - Collaborative projects for better health autumn 2022

Purpose and goal

The project aims at testing two diagnostic test prototypes in relevant end-user environment and verifying their applicability for clinical use for faster diagnosis and correct prognosis for rheumatoid arthritis patients.

Expected effects and result

During the project, system components, processes and device prototype will be validated and demonstrated in the end user environment. Possible new areas of use are investigated and the strategy to protect intellectual property rights will be completed.

Planned approach and implementation

The project is led by a company developing the test for commercialization and the other partners represent the innovator, healthcare, and clinical laboratories as end users. Usability studies are carried out in relevant end-user laboratory, the test developed based on both the user requirements and the regulatory requirements. Research to discover new areas of use is done in parallel.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 24 May 2023

Reference number 2022-03476